SCHEMBL4505532

SCHEMBL4505532

CCOC(=O)c1ccn2c(C(=O)c3ccc(NC(=O)C(F)(F)F)c(OC)c3)nc(N)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.41
▸ ABCC9 O60706 1/20 0.40
▸ ABCC8 Q09428 1/20 0.40
▸ KCNJ11 Q14654 1/20 0.40
▸ KCNJ8 Q15842 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ PTGER4 P35408 3/20 0.39
▸ HSD17B2 P37059 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ TP53 P04637 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ ALDH1A1 P00352 5/20 0.37
▸ HPGD P15428 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ USP2 O75604 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1573154 0.89 ABCC9 (0.45) ABCC9ABCC8KCNJ11KCNJ8KMT2A
SCHEMBL4497581 0.84 ABCC9 (0.41) ABCC9ABCC8KCNJ11KCNJ8TP53
SCHEMBL4519503 0.81 ABCC9 (0.36) ABCC9ABCC8KCNJ11KCNJ8KDM4E
SCHEMBL4519504 0.79 NR1H4 (0.37) ABCC9ABCC8KCNJ11KCNJ8MAPT
SCHEMBL1573133 0.71 ABCC9 (0.40) ABCC9ABCC8KCNJ11KCNJ8MAPT
SCHEMBL4420899 0.68 ABCC9 (0.47) ABCC9ABCC8KCNJ11KCNJ8LMNA
SCHEMBL7078236 0.68 CYP1A2 (0.55) ABCC9ABCC8KCNJ11KCNJ8KDM4E
SCHEMBL12392964 0.67 PDK1 (0.48) ALOX15GAAPTGER4HSD17B2KDM4E
SCHEMBL15985814 0.67 HSD17B2 (0.58) ALOX15GAAPTGER4HSD17B2MAPT
SCHEMBL15903926 0.66 ABCC9 (0.58) ABCC9ABCC8KCNJ11KCNJ8KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 ALOX15 3658/4885ABCC9 3947/4885ABCC8 3724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback